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Abstract Hippocampal sclerosis (HpScl) is characterized
by neuronal loss and gliosis in CA1 and subiculum of the
hippocampus, and may be one contributing factor to
dementia in old age. The term hippocampal sclerosis
dementia (HpSclD) designates the presence of both hippo-
campal sclerotic lesions and a dementia syndrome. In the
present review, we outline the pathological heterogeneity
underlying HpSclD and discuss related disorders due to tau
protein pathology and frontotemporal dementia with ubiqu-
itin positive inclusions (FTLD-U). We also provide a
detailed morphological description of ten of our own autop-
sied HpSclD cases, and compare these pathological Wnd-
ings with those reported in the literature. The lateralization
of HpScl and the atrophy of the mammillary bodies were
striking features in most of our cases. The main pathology
consisted of tau positive lesions with a predominance of
neuronal and glial pretangles in Ammon’s horn and the
dentate gyrus. NeuroWbrillary and ghost tangles in CA1 and
the subiculum were scarce and thus insuYcient to explain
the hippocampal pyramidal cell loss. In some cases, tau
pathology in the hippocampal formation coexisted with
glial tau pathology in the frontal cortex. The most striking
Wnding besides the tau pathology was the presence of con-
comitant neuronal cytoplasmic inclusions and neurites
immunoreactive for the transactive response DNA-binding
protein-43 (TDP-43) in the dentate gyrus and temporal neo-
cortex, similar to those found in FTLD-U. Taken together,
the pathology of HpSclD is indicative of a degenerative
rather than a hypoxic/ischemic etiology of HpSclD. Pres-
ently, HpSclD may best be deemed a disorder with various
neurodegenerative etiologies, most notably tauopathy and
TDP-43 proteinopathy (i.e. FTLD-U). Each of these disease
processes could either independently or concertedly
account for the dementia syndrome in HpSclD.
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Introduction
Dementia is one of the most serious conditions aVecting
elderly individuals. While Alzheimer’s disease (AD) is the
most common cause of dementia in the very old (i.e.
80 years of age and older), other conditions are also prefer-
entially associated with dementia in this age group, in par-
ticular argyrophilic grain disease (AgD) [11, 20, 40], senile
dementia of the neuroWbrillary tangle type [24, 42, 46], and
hippocampal sclerosis (HpScl) dementia (HpSclD) [19].
HpScl is a selective neuronal loss and astrocytic gliosis
of the hippocampus, with a predilection for the cornu
ammonis Weld CA1 and subiculum [18, 19]. In the majority
of cases, HpScl in very old individuals coexists with
dementia [8, 18, 30], and this syndrome is referred to as
HpSclD.
Neuronal loss and gliosis is also prominent in CA1 in
seizure-associated “mesial temporal sclerosis” or “Ammon’s
A. Probst · M. Tolnay (&)
Department of Neuropathology, Institute of Pathology, 
University Hospital Basel, Schönbeinstrasse 40, 
Basel 4031, Switzerland
e-mail: mtolnay@uhbs.ch
K. I. Taylor
Department of Experimental Psychology, 
University of Cambridge, Cambridge CB2 3EB, UK
K. I. Taylor
Memory Clinic-Neuropsychology Center, 
University Hospital Basel, Basel 4031, Switzerland123
336 Acta Neuropathol (2007) 114:335–345horn sclerosis”, mainly following prolonged seizures in
early infancy. Contrary to the HpScl seen in elderly indi-
viduals, however, the CA4 sector is often also severely
involved and may even bear the brunt of damage. In such
cases, the granular layer of the dentate gyrus may be
severely depleted, disorganized and essentially dispersed in
the gliotic tissue (see [13] and references therein). Some
neuronal loss in the endplate and the granule cell layer of
the dentate gyrus is occasionally found in HpSclD [19] but
is atypical [2, see also the Wndings in our own cases below].
The etiology of HpSclD is uncertain. HpSclD is com-
monly associated with vascular encephalopathy or a degen-
erative disorder, particularly AD [6, 15, 17, 19, 23, 45] and
frontotemporal lobar degeneration with ubiquitin immuno-
reactive inclusions (FTLD-U) [9, 22]. The large number of
neuropathologies associated with HpSclD (see Table 1)
suggests that more than one mechanism of hippocampal
cell destruction may be involved. Indeed, HpSclD could
conceivably be caused by any one of the associated
nosological conditions, or, alternatively, by several neuro-
pathological processes acting in concert.
This review focuses on the pathological aspects of
HpSclD and the various nosological conditions with which
it is associated, most notably FTLD-U and disorders hall-
marked by tau protein cellular inclusions (i.e. AD). We will
discuss the role of vascular lesions, as some authors have
suggested that HpScl represents a marker for vascular
dementia or cerebral ischemia [18, 43]. We also report
detailed morphological Wndings from ten of our own autop-
sied HpSclD cases, and discuss their histopathological fea-
tures in relation to previous reports on HpSclD pathology.
Our Wndings highlight some hitherto neglected features of
HpSclD, such as the hemispheric lateralization of lesions
and secondary shrinkage of the mammillary bodies which
may prove to be valuable brain imaging markers for the
diagnosis and diVerential diagnosis of HpSclD.
Demographics and clinical characteristics of HpSclD
The prevalence of HpSclD among dementia patients is
12–13% [7, 30]. The mean age of onset of HpSclD has
been situated at 79.8 (§1.4) years [30], comparable to the
age of onset of AD patients [7, 30]. The age of death of
HpSclD patients most likely depends on the presence, type
and severity of concomitant pathology. Thus, patients with
concomitant HpSclD and AD may die later [7, 17] than
patients with HpScl and dementia lacking distinctive histol-
ogy (DLDH) (72 years) [25] or patients with HpScl and
FTLD-U (65 years) [2]. However, patients with concomi-
tant AD and HpScl pathology died earlier than pure AD
cases [6]. The frequency of HpSclD in men and women is
comparable [7].
The relationship between HpScl and dementia has often
been considered a problem since pure hippocampal damage
without concomitant lesions in other parts of the brain nor-
mally produces pure anterograde amnesia, but not impair-
ments in an additional cognitive domain that would warrant
a clinical diagnosis of dementia and impairments in daily
living (DSM-IV) [4, 18]. However, isolated cases of HpScl
have been reported with less severe changes of the hippo-
campi and clinical deWcits restricted to the amnestic
domain. For example, HpScl was clinically diagnosed in a
patient with a 1-year history of amnestic mild cognitive
impairment (aMCI) [39]. T2-FLAIR-weighted images
revealed bilaterally altered signal in the hippocampi but no
evidence of hippocampal atrophy. Interestingly, this
patient’s cerebrospinal Xuid beta-amyloid (1–42) concen-
tration was low (565 pg/ml; normal values: 943§258 pg/
ml) and phospho(181)-tau concentration increased (68 pg/
ml; normal values <61 pg/ml), reXecting the proWle found
in AD [10]. Correspondingly, a neuropathologic study of
aMCI found HpScl lesions in 3 of 15 patients [37]. All
three patients evidenced NFT pathology corresponding to
Braak stage II (2 cases) or III [12], and argyrophilic grains
(ArGs) were additionally found in two cases. Thus, when
HpScl pathology is less severe and restricted to anterome-
sial temporal lobe structures, the clinical expression
appears restricted to amnestic deWcits.
However, in most reported series [8, 9, 17], patients
presented with memory and other cognitive problems, as
well as decrements in activities of daily living, consistent
with the diagnosis of dementia (DSM-IV [4]). The primary
cognitive disturbances in HpSclD are similar to those in AD
[17, 18, 30], i.e. signiWcant deWcits in episodic memory func-
tioning and language (i.e. picture naming). HpSclD patients
appear less impaired on measures of visuospatial and executive
Table 1 Conditions found to be associated with hippocampal
sclerosis dementia
FTLD-U frontotemporal dementia with ubiquitin positive inclusions
Hippocampal sclerosis dementia, “pure” form [1].
Amnestic mild cognitive impairment 
(no pathological conWrmation) [37, 39].
FTLD-U with and without progranulin mutations 
(i.e. TDP-43 proteinopathy) [3, 9, 17, 22, 28].
Dementia lacking distinctive histology [29].
Frontotemporal dementia with motor neuron disease [34].
Limbic tauopathy with features of FTLD-U 
(TDP-43 proteinopathy) [present study].
Sporadic multisystem tauopathy [8].
Alzheimer’s disease [6, 17, 19, 23].
Argyrophilic grain disease [8, 19].
Corticobasal degeneration [38].
Dementia with Lewy bodies [19].
Vascular encephalopathy [43].123
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[17, 30]. While a recent study [9] reported that the cumula-
tive prevalence of behavioral deWcits in HpSclD patients
(with no concomitant pathology) were more similar to those
of an unmatched group of frontotemporal lobe dementia
(FTD) patients than a matched AD group, no data on the
severity of these symptoms, nor neuropsychological test data,
were available. Thus, the clinical dementia syndrome associ-
ated with HpScl appears to mimic AD, consistent with the
primary loci of pathology in these two syndromes.
Brain imaging
Information on the structural brain imaging correlates of
HpSclD is scarce. Unilateral or bilateral hippocampal atro-
phy together with an increased hippocampal T2-weighted
signal constituted the prominent Wndings in the HpSclD
patients reported by Mahieux et al. [32]. Notably, elevated
T2-weighted signal is not a feature of the hippocampal atro-
phy associated with AD [33]. Increased signal intensity on
T2-weighted scans was found in the periventricular white
matter and centrum semiovale in the three of four HpSclD
patients who received MRI scans in the study of Dickson
et al. [19]. Unfortunately, less attention was prested to the
structural integrity of these patients’ hippocampi as mea-
sured by MRI. However, all 13 patients in this study
received CT scans, which showed an attenuation of signal
in the periventricular white matter consistent with leukoara-
iosis in four and infarcts in three patients.
Neuropathology of ten own HpSclD cases
Ten cases who met the morphological criteria for HpScl
were collected over a period of 10 years in our Institute.
HpScl was deWned as a neuronal loss and astrocytic gliosis
restricted to the cornu ammonis of the hippocampus
(mainly CA1) and the subiculum with occasional extension
of lesions to the parahippocampal gyrus (i.e. entorhinal,
perirhinal and parahippocampal cortices). All patients died
at an advanced age (Table 2), and dementia was docu-
mented in all cases for which clinical data were available
(9/10 cases). Two patients were neuropsychologically
examined, and received diagnoses of multiple domain MCI
(case 7) and probable AD (case 8).
Gross Wndings
All ten HpScl cases showed moderate to severe volume loss
in the hippocampus and adjacent subiculum (Fig. 1a, b).
Some showed atrophy of the entire mesial temporal cortex
including the parahippocampal gyrus. One or both mam-
millary bodies were reduced in size and altered in color in
the majority of patients (6/10 cases) (Fig. 1b). Case 8 addi-
tionally had enlarged lateral ventricles and an old encepha-
lomalacia in the left temporo-occipital region. No gross
ischemic cerebral lesions or lacunar infarcts were observed
in the remaining cases.
Microscopic appearance
The main histological features in the hippocampus, subicu-
lum, entorhinal cortex and middle frontal gyrus are listed in
Tables 3 and 4. Neuronal cell loss and gliosis were
restricted to the CA1 sector and the subiculum in four cases
(Fig. 1c). Cell loss and gliosis extended to other temporom-
esial structures, mainly the entorhinal and temporobasal
cortices, in six other cases (Fig. 1d). The amygdala was
severely gliotic in case 8 and contained abundant NFT and
senile plaques. The amygdala of the remaining cases
showed only moderate astrocytic gliosis with scattered
Table 2 Clinicopathological 
Wndings in our hippocampal 
sclerosis dementia cases
Case Gender Age Dementia Brain 
weight (g)
Neuropathological Wndings 
(see also Tables 3 and 4)
1 F 94 n.a. n.a. Atrophy of mammillary bodies
2 F 90 Yes n.a. –
3 M 84 Yes 1,080 Cribriform state of the striatum
4 F 95 Yes 1,270 Atrophy and gliosis of ncl. accumbens, 
Atrophy of mammillary bodies 
5 F 84 Yes 990 ArGs of right hippocampus and entorhinal cortex, 
Atrophy of mammillary bodies
6 M 90 Yes 1,430 –
7 M 79 Yes 1,340 Severe microangiopathy
8 M 88 Yes 1,350 Old infarction of the left occipitotemporal region, 
Atrophy of mammillary bodies
9 F 89 Yes 980 Atrophy of mammillary bodies
10 F 90 Yes 1,000 Atrophy of mammillary bodiesArGs argyrophilic grains, 
n.a. not available123
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more marked and hippocampal volume loss more pro-
nounced in one hemisphere, with the majority of cases
showing more left hemisphere involvement (5/7). Sclerotic
lesions were focally distributed in the hippocampi in most
cases. Only one case showed an asymmetry of lesion load
along the anterior to posterior axis of the hippocampus,
with the anterior hippocampus more severely aVected (case
3). Severe microangiopathic changes were observed in the
basal ganglia of case 7. Vascular Wbrosis with thickening of
small leptomingeal hippocampal arteries was observed in
case 4. No cases showed a calciWcation of the hippocampal
microvessels [44]. Staining with H&E revealed varying
degrees of neuronal loss and an evident contraction of the
pyramidal layer in CA1, but less pronounced shrinkage in
the subiculum. Devastation of nerve Wbers in the alveus and
the Wmbria hippocampi was observed to varying extents. In
some cases, the CA1 sector and the subiculum were almost
completely depleted of nerve cells with the exception of
some swollen neurons which were often Wlled with granu-
lovacuoles (data not shown). The neuropil of CA1 was vac-
uolated in all cases and often appeared lucent due to more
severe cell and neuropil loss, whereas brain parenchyma
was better preserved in the subiculum (Fig. 1c). Large
gemistocytic astrocytes were observed in the subiculum,
suggesting acute or more recent tissue damage, whereas
CA1 mainly contained Wbrous astrocytes compatible with a
chronic gliosis. Pyramidal shaped empty spaces (reminis-
cent of “empty cell beds” described in motor neuron dis-
ease), often Wlled with cell remnants, were found in the
hippocampus (cases 5, 8 and 10), suggesting ongoing
destruction of pyramidal cells (Fig. 2a).
The principal pathology consisted of tau immunoreac-
tive lesions in neurons and glial cells, as observed using the
phosphorylation-dependent anti-tau antibody AT8. The
main lesion consisted of a diVuse intracytoplasmic reactiv-
ity for tau in CA1 (Fig. 2b), CA2 and CA3-4 (Fig. 2c) neu-
rons and in the granule cell layer of the dentate gyrus
(Fig. 5a). Tau positive threads were found scattered in the
sclerotic CA1 as well as in the alveus-Wmbria tracts. Most
tau immunoreactive lesions corresponded to “pretangles”
as they were not stained by the Gallyas technique. One
exception consisted of NFT in sectors CA4 and CA2
(Fig. 2d). In cases 2 and 3, numerous “ghost tangles” were
found selectively in sector CA2 of the hippocampus. ArGs
were present in the anterior part of hippocampal sector CA1
in case 5 (Fig. 2f). Immunohistochemistry with monoclonal
antibodies directed against three- (3R) or four-repeat (4R)
tau isoforms revealed an admixture of 3R and 4R tau in all
our cases (Figs. 3a–c). Thus, NFT stained for both 3R and
4R antibodies (with a preponderance for 4R tau in “pretan-
gles” and 3R tau in “ghost tangles”; reviewed in [24]) while
ArGs, tufted astrocytes and astrocytic plaques (see below)
were exclusively stained with the 4R antibody. None of our
cases, however, met the current diagnostic criteria for one
of the 4R tauopathies AgD, PSP or CBD.
Numerous NFT, “ghost tangles” (Fig. 2e) and “pretan-
gle” neurons were found throughout the entorhinal and
perirhinal cortices in cases 1–4, and 8. Especially in cases
with numerous “ghost tangles” in layer II of the entorhinal
Fig. 1 a,b T1-weighted MRI 
image of case 8. Severe 
hippocampus and temporo-
mesial atrophy on both sides. 
Considerably enlarged temporal 
horns, right-lateralized. Also 
note the severe atrophy of the 
mammillary bodies. b Macro-
scopic view of case 10 reveals 
atrophy of the anterior hippo-
campus and severe atrophy and 
discoloration of the mammillary 
body (arrow) c Case 8 stained 
with H&E shows neuronal loss 
in sector CA1 of the hippocam-
pus and subiculum and second-
ary degeneration of the alveus 
and Wmbria. Note better preser-
vation of the cell population in 
CA3-4 and in the dentate gyrus 
and the looser neuropil texture in 
CA1 than in the subiculum. d In 
case 4, cell loss and gliosis 
extend to the entorhinal and tran-
sentorhinal cortices123
Acta Neuropathol (2007) 114:335–345 339cortex, diVuse neuronal loss with blurred cortical lamina-
tion and shrinkage of the cortical ribbon was observed.
Tau and Gallyas positive cellular structures were also
found in the cerebral cortex in some cases. These lesions
consisted of tufted astrocytes (Fig. 4a) and some “pretan-
gle” neurons. Both tufted astrocytes and astrocytic plaques
were found in case 8 (Fig. 4b, c). No evidence of vacuola-
tion or astrocytic gliois was found in the temporal and
frontal cortices. A small number of ubiquitin immunoreac-
tive (tau and alpha-synuclein negative) neuronal cytoplas-
mic inclusions and neurites were found in the temporal
cortices of cases 3, 8, and 9. In these cases, ubiquitin reac-
tive cytoplasmic and intranuclear inclusions (Fig. 5b) were
also found in the granule cells of the dentate gyrus. These
ubiquitinated inclusions were strongly stained with an
antibody directed against the transactive response DNA-
binding protein-43 (TDP-43) (Fig. 5c, d). Thus, in some
cases we observed the simultaneous occurrence of AT8
positive/Gallyas negative, ubiquitin and TDP-43 immuno-
reactive inclusions in granule cells of the dentate gyrus
(Fig. 5a–c).
Additional neuropathological Wndings consisted of a
small number of alpha-synuclein stained Lewy bodies and
Lewy neurites in the hippocampal regions and middle fron-
tal gyrus in one case (case 6) and some diVuse beta-amyloid
plaques in Wve cases (Tables 3 and 4).
Table 3 Main histological lesions in hippocampus and subiculum
Ecb empty cell beds, SP senile plaque (mainly diVuse plaques), L left, R right, CA cornu ammonis, T tangles, Th threads, p.t. pretangle neuron, DG
dentate gyrus, Sub subiculum, GT ghost tangles, ant anterior, post posterior, Presub presubiculum, ArGs argyrophilic grains, LB Lewy bodies, LN
Lewy neurites, TDP-43 TDP-43 stained intracellular and/or intranuclear inclusions in granule cells of the dentate gyrus, + few, ++ moderate, +++,
abundant, – absent
Case Site Histological features and immunohistochemistry
Neuron loss Ecb 
in CA1
Vacuolation SP Gallyas AT8 TDP-43 -Syn
1 L = R CA1, Sub++ – CA1++ – T, Th+ in CA2, 
CA4, Alveus (glia)
p.t. in CA1–4++, 
DG+, Alveus (glia)
– –
2 L = R CA1+++, Sub++ + CA1++ – GT+++ in CA2, T+ in CA4 p.t. in CA1–3++ – –
3 L = R CA1, Sub+++ + CA1–4++ – GT++ in CA2, T+ in CA4 p.t. in CA1–4, DG++, 
Th++ in CA4, Alveus
+ –
4 L > R CA1, Sub, 
Presub+++
+ CA1++ – T+ in CA3–4 p.t. in CA2–4, DG+ – –
5 L > R CA1++ ++ CA1, Sub+ – ArGs+ p.t. CA1–4++, ArGs++ – –
6 L > R CA1, Sub++ + CA1+ + – p.t. CA1–4++ – LB, LN+
7 L >> R CA1, Sub++ + CA1+ – T+ in CA1 p.t. in CA1–4, DG+ – –
8 L << R CA1, Sub+ + CA1++ – T+++ in CA2, 
CA4, T+ in CA1
p.t. in CA1+, DG++ + –
9 L >> R CA1, Sub+++ – CA1+++ + – p.t. in CA1, DG+ + –
10 L << R CA1, Sub++ ++ CA1+++ – – p.t. in CA1–4+ – –
Table 4 Main histological 
Wndings in the middle frontal 
gyrus
Case Vacuolation 
in layer II–III
Gallyas+ inclusions AT8 SP TDP-43* -Syn
1 – TA+ TA+, p.t.+ – –
2 – TA+ TA+ + –
3 – TA+ p.t.+, th+, TA+ – –*
4 – – – – –
5 – – p.t.+ – –
6 – – p.t.+ + – LB, LN+
7 – – TA+ + –
8 – TA++, T+, AP+ TA++, T+, AP+ ++ –*
9 – – – + –*
10 – – – – –
SP senile plaques (mainly 
diVuse plaques), TA tufted 
astrocyte, p.t. pretangle neurons, 
th threads, LB Lewy bodies, LN 
Lewy neurites, AP astrocytic 
plaque, TDP-43* few TDP-43 
stained intracellular inclusions 
and neurites were present in the 
temporal cortex, + few, 
++ moderate, – absent123
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Pathological Wndings in HpSclD
HpScl is deWned as a selective neuronal loss and gliosis of
CA1 and the subiculum of the hippocampus. An extension
of lesions to the mesial temporal cortex including the
entorhinal cortex or entire parahippocampal gyrus and to
the amygdala has been reported [19, 30] and was also
evident in some of our cases.
HpScl has been reported in patients with a variety of
neuropathological diseases (see Table 1) including AD [6,
15, 17, 19, 23, 45], AgD [19], and some other tauopathies
[8, 38], dementia with Lewy bodies (DLB) [19], vascular
Fig. 2 a–e CA1, case 5. 
Pyramidal-shaped empty spaces 
in the neuropil, probably 
corresponding to destroyed 
neurons (reminiscent of “empty 
cell beds”). b CA1, case 1. 
Immunostaining with 
phosphorylation-dependent  
anti-tau antibody AT8. 
“Pretangle” pyramidal cells in 
the cortical ribbon and myriads 
of AT8-labelled structures, 
probably corresponding to glia, 
in the stratum oriens and the 
alveus. c CA4, case 3. AT8 
stained “pretangle” neurons. 
d CA2, case 8. Abundant 
Gallyas stained neuroWbrillary 
tangles. e Entorhinal cortex, case 
3. Gallyas stained “ghost 
tangles” in layer II. f CA1, case 
5. Gallyas stained argyrophilic 
grains
Fig. 3 a Immunohistochemistry with an antibody directed against
four-repeat (4R) tau isoforms stains a “pretangle” neuron in sector
CA4 in case 6. b Numerous “ghost tangles” in addition to some NFT
are stained with an antibody against three-repeat tau isoforms in sector
CA2 in case 3. c Strongly 4R stained argyrophilic grains, “pretangles”
and a NFT in sector CA1 in case 5123
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progranulin gene mutations [9, 21, 25, 26, 28, 31]. HpSclD
may also be associated with the DLDH syndrome insofar as
the majority of these cases most likely correspond to
FTLD-U. Variable degrees of hippocampal atrophy or even
sclerosis have been reported in DLDH [21, 27], and a retro-
spective search for ubiquitin positive inclusions was posi-
tive in the dentate gyrus and/or frontotemporal cortices in
more than 70% of cases in one study [25], consistent with a
diagnosis of FTLD-U.
Ubiquitinated, tau negative neuronal cytoplasmic inclusions
as well as neurites and lentiform intranuclear inclusions
constitute the deWning histological features of FTLD-U.
Not surprisingly, such features have been reported in the
dentate gyrus of all reported HpScl cases diagnosed with
FTLD-U, but these features may have extended to frontal
and temporal cortices in some cases [22] (as in the present
series temporal involvement in cases 3, 8 and 9). TDP-43
has been identiWed as the main protein constituent of the
neuronal inclusions of most FTLD-U entities with and
without associated motor neuron disease [5, 35]. Both our
Wndings and recent studies have shown that a signiWcant
proportion of HpSclD cases in the elderly have TDP-43
immunoreactive inclusions and neurites similar to those of
FTLD-U [3, 14], consistent with previous studies using
ubiquitin immunohistochemistry to investigate the fre-
quency of FTLD-U in HpScl [16]. Patients with concomi-
tant HpScl and FTLD-U pathology may show more
pronounced cortical atrophy than patients with isolated
HpScl lesions [27], as well as a dementia syndrome with
clinical features of FTD [9, 22].
HpSclD has also been tentatively considered a sporadic
multisystem tauopathy, for which the term “hippocampal
sclerosis dementia with tauopathy” was introduced [8].
Further, the pathological evidence suggests that at least
some HpSclD cases occur within the pathological frame-
work of a sporadic multisytem tauopathy. For example, 12
out of 14 HpSclD cases reported by Beach et al. [8]
Fig. 4 a–c. Cerebral cortex, case 8. a Gallyas positive tufted astrocyte. b Gallyas and c AT8 positive astrocytic plaque
Fig. 5 a–c. Dentate gyrus, case 
3. a AT8 reveals numerous 
positive granule cells. These 
cells were Gallyas negative and 
correspond to “pretangle” 
neurons. b Ubiquitin positive 
lenticular inclusions in granule 
cells nuclei. c Rod or half moon 
shaped TDP-43 positive 
intracytoplasmic inclusions in 
granule cells. Note TDP-43 
clearing of the nucleus in cells 
containing inclusions. 
d Temporal cortex, case 3. TDP-
43 positive inclusions in the 
cytoplasm of neurons and TDP-
43 positive threads123
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sions in nerve and glial cells in the neocortex, basal
ganglia, thalamus and/or limbic regions, and a majority of
their cases also showed ArGs. Similar to the cases of
Beach et al. [6], the main pathology in our cases consisted
of tau immunoreactive “pretangle” and tangle lesions in
nerve cells and glia, but with a more restricted anatomic
distribution centered mainly in the hippocampus/subicu-
lum and the frontal cortex. The distribution of tau pathol-
ogy in the present series also diVers from that encountered
in AD and is more reminiscent of tau pathology observed
in 4R tauopathies [47]. As noted above, the most striking
Wnding apart from tau pathology consisted of neuronal
inclusions and neurites immunoreactive for ubiquitin and
TDP-43 in the dentate gyrus and the temporal neocortex,
similar to those characterizing FTLD-U [5, 35]. Thus,
simultaneous occurrence of AT8 positive/Gallyas nega-
tive, ubiquitin and TDP-43 immunoreactive inclusions was
observed in the granule cells of the dentate gyrus and in
other parts of the hippocampus in a subset of our cases. It
remains unclear whether the TDP-43 immunoreactivity
observed in our cases merely reXects a propensity for the
co-deposition of a nosologically irrelevant protein in addi-
tion to tau protein, or if HpSclD results from two concur-
rent disease processes. Indeed, HpSclD may arise from the
combined eVects of a tauopathy and a TDP-43 proteinopa-
thy, from a tauopathy alone, or a TDP-43 proteinopathy
alone. Irrespective of the pathogenesis of the dementia
syndrome, the present series suggests that the hallmarks of
a tauopathy and a TDP-43 proteinopathy may coexist in
some HpSclD cases.
The problem of “pure” HpSclD
Occasionally (0.4–2% of autopsies of elderly subjects)
HpScl is found to be an independent pathologic explanation
for a clinical dementia syndrome—so-called “pure”
HpSclD [1, 7, 9, 19, 23, 31]. In such cases, no or only slight
evidence for a concomitant degenerative disorder is associ-
ated with HpScl, and lesions are largely restricted to the
CA1 sector and the adjacent subiculum. Additional criteria
for this diagnosis should be the absence of cerebrovascular
pathology or clinical evidence of syncope, hypotension or
hypoxia in association with dementia onset. However, the
real prevalence of “pure” HpSclD is diYcult to assess from
the reported cases and will conceivably depend on the neu-
rodegenerative lesion load, especially the degree of neuroW-
brillary changes, “allowed” to be associated with HpScl as
part of a normal aging process. Considering the advanced
age of patients with HpSclD, “pure” HpSclD is likely to be
an exceptional occurrence if the absence of neuroWbrillary
changes is required for the diagnosis. An arbitrary limit
based on neuroWbrillary tangles has been proposed by Ala
et al. [1], with cases below Braak stage II [12] considered
compatible with “pure” HpSclD.
Evidence for diVerentially aged lesions in HpSclD
Lesions at diVerent stages were found in the hippocampus
of a case reported by Leverenz et al. [30] and considered
consistent with a progressive neurodegenerative process.
Gliosis within individual cases demonstrated acutely reac-
tive gemistocytic glia in some regions of the CA1 and
chronic gliosis within other regions of CA1. In the present
case series, we also found diVerences in reactive glia, with
more gemistocytic astrocytes in the subiculum and more
Wbrous astrocytes in the CA1. The appearance of the neuro-
pil also suggested diVerent ages of the sclerotic lesions in
these two areas: while CA1 often appeared “empty” of neu-
ropil texture, the subiculum appeared more preserved.
These Wndings suggest that the pathological process in
HpSclD starts in CA1 and then progresses to the subicu-
lum. Also in accord with this assumption is the fact that in
most published HpSclD cases neuronal loss has been noted
both in the subiculum and CAI while in some cases cell loss
was only observed in CA1 [2]. However, in this same study
[2] there were two cases of HpScl associated with FTLD-U
that had isolated subicular involvement. Further studies will
show if the local progression and the initiation site for neu-
ronal loss may diVer in HpScl with and without FTLD-U.
Is HpSclD due to a vascular disease process?
The hippocampus appears to be preferentially vulnerable to
a variety of pathologic insults including seizures, hypoxia
and neurodegeneration (e.g. AD). Particularly the CA1
region and the subiculum are thought to be prone to hyp-
oxic/ischemic injury due to the deWcient vascular supply of
the hippocampus and the fact that CA1 neurons are richly
endowed with glutamate receptors which may be involved
in excitotoxic cell death [36]. However, the evidence to
support vascular injury as a contributing factor to HpScl in
the demented elderly is indirect and contradictory. Both the
hemispheric asymmetry of lesion load in our own and pre-
viously reported cases (see below) and the focal distribu-
tion of lesions in the hippocampi favor a hypoxic/ischemic
etiology. However, microvascular calciWcation of intrahip-
pocampal vessels found to be associated with HpScl [44]
were consistently absent in our cases and signiWcant wall
thickening of hippocampal arterioles only observed in one
of our cases.
Cardiac disease is a frequent concomitant of HpSclD in
some studies [17, 19, 43], and signiWcant cardiovascular
disease or a history of myocardial infarction was found in
the HpSclD series reported by Dickson et al. [19]. Patho-
logical Wndings have been inXuential in this debate, with123
Acta Neuropathol (2007) 114:335–345 343observations of leukoaraiosis, microinfarcts, and encepha-
lomalacias leading Dickson et al. [19] to suggest that HpScl
in their cases resulted from hypoxia/ischemia. However,
other authors have failed to Wnd increased cardiovascular
risk factors in their HpSclD cases [23]. Moreover, while
pathological evidence for cerebrovascular disease was
found in 75% of HpSclD cases reported by Amador-Ortiz
et al. [2], this frequency was comparable to that of a control
group of similar age, gender and Braak stage. Notably, in
this comparative study cerebrovascular pathology was
found in “pure” HpScl cases but rarely in HpScl cases with
FTLD-U [2]. In a large prospective longitudinal study on
vascular ischemic dementia and AD, enriched with subcor-
tical ischemic vascular disease, HpScl was a common
unsuspected Wnding [15]. HpScl was found less frequently
in pure AD, compared with mixed AD/cerebrovascular dis-
ease (CVD), CVD, or no signiWcant AD or CVD pathology,
but these diVerences were not signiWcant [15]. In summary,
however, most data from the literature do not support the
hypothesis that episodes of syncope, hypotension, or
hypoxia are precipitating factors for HpScl in demented
patients [2, 17, 19].
Hemispheric lateralization of HpScl lesions and atrophy 
of the mammillary bodies
The hemispheric asymmetry of HpScl lesion load is noted
in some published series of HpSclD [8, 30]. For example,
Beach et al. [8] found unilateral HpScl in 5 of their 14
cases. However, these authors had only one contralateral
anteroposterior plane at their disposal, and noted the possi-
bility that HpScl may have been bilateral in all their cases.
Indeed, HpScl lesions often have a patchy distribution
along the hippocampus/subiculum, as evidenced in our
cases. Most published pathological case series of HpSclD
do not expressly mention the hemispheric lateralization of
HpScl lesions nor the patchy distribution of HpScl. Further-
more, some case series only have one hemisphere available
for examination [1]. In our own case 1, diVerent patterns of
lesion asymmetry were observed in the anterior and poster-
ior hippocampal regions, with only mild sclerotic changes
observed in the left subicular area and extensive sclerosis in
the CA1, subiculum, presubiculum and entorhinal area on
the right side. Thus, in spite of an evident asymmetry of
lesions in some cases, the incidence of unilateral HpScl
remains diYcult to assess. Ideally, complete reconstruction
of the “sclerotic” hippocampus should be performed using
continuous (gap-less) anteroposterior sampling on both
sides.
Uni- or bilateral shrinkage and discoloration of the mam-
millary bodies was a prominent feature in some of our cases
and is likely to result from Wmbria-alveus degeneration as a
consequence of CA1 devastation. A 20% reduction in
mammillary body size has also been reported in AD com-
pared to MCI and control participants [16]. The degree of
mammillary body shrinkage observed in some of our cases
(Fig. 1a, b) was certainly greater than 20%. Moreover,
mammillary body shrinkage was asymmetric in most of our
cases. Thus, on MRI images, severe and lateralized mam-
millary body shrinkage together with T2 signal hyperinten-
sities could aid the diVerentiation of HpSclD from AD.
Genetic factors in HpSclD
Scant genetic data exist on HpSclD, and the majority of
available data concerns apolipoprotein E. Troncoso et al.
[41] reported an apolipoprotein E4 (apoE4) allele fre-
quency of 12.5% in their 12 cases of autopsy-conWrmed
HpSclD, a frequency similar to that of a control population
and signiWcantly lower than the frequency observed in AD
populations (see also [30]). Also Josephs et al. [25]
reported a frequency of apoE4 alleles in their patients with
concomitant HpSclD and DLDH similar to the normal pop-
ulation. Similarly, both genotyped aMCI patients patholog-
ically diagnosed with HpScl had an apoE3/E3 constellation
in the study of Petersen et al. [37]. These results suggest
that apoE4 is neither a risk nor a pathogenic factor for
HpSclD, and that HpSclD is biologically diVerent from
AD.
Conclusions
HpScl is one histomorphological substrate of dementia in
old age. The present and previously reported pathology
Wndings strongly suggest a degenerative rather than a hyp-
oxic/ischemic etiology for HpSclD. At present, HpSclD
may best be deemed a dementing disorder with various
neurodegenerative etiologies, in particular tauopathy and
TDP-43 proteinopathy. Clearly, further studies on larger
samples of HpSclD cases are needed in order to unravel the
pathogenic implications of tau and TDP-43 and their possi-
ble relationship in HpScl as well as the real incidence of
“pure” HpSclD cases.
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